Articles published by Athira Pharma, Inc.
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
May 15, 2024
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
February 22, 2024
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
November 09, 2023
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma to Participate in Jefferies London Healthcare Conference
November 08, 2023
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma to Participate in Upcoming October Conferences
September 28, 2023
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 19, 2023
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
August 10, 2023
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
![](https://ml.globenewswire.com/media/725c8461-70fe-413a-af54-fd6a7e193f0d/small/athira-pharma-logo-rgb-1200px-jpg.jpg)
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
May 22, 2023
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers
ATHA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.